Borm, Kai J.
Behzadi, Sophie T.
Hörner-Rieber, Juliane
Krug, David
Baumann, Rene
Corradini, Stefanie
Duma, Marciana Nona
Dunst, Jürgen
Fastner, Gerd
Feyer, Petra
Fietkau, Rainer
Haase, Wulf
Harms, Wolfgang
Hehr, Thomas
Matuschek, Christiane
Piroth, Marc D.
Schmeel, Leonard Christopher
Souchon, Rainer
Strnad, Vratislav
Budach, Wilfried
Combs, Stephanie E.
,
Funding for this research was provided by:
Technische Universität München
Article History
Received: 3 January 2024
Accepted: 7 January 2024
First Online: 15 March 2024
Conflict of interest
: K.J. Borm has received honoraria from Accuray. D. Krug has received honoraria from Merck Sharp & Dome, med update, onkowissen, best practice onkologie, ESO, ESMO, Gilead, Astra Zeneca, and Pfizer as well as research funding from Merck KGaA. S.T. Behzadi, J. Hörner-Rieber, R. Baumann, S. Corradini, M.N. Duma, J. Dunst, G. Fastner, P. Feyer, R. Fietkau, W. Haase, W. Harms, T. Hehr, C. Matuschek, M.D. Piroth, L.C. Schmeel, R. Souchon, V. Strnad, W. Budach and S.E. Combs declare that they have no competing interests.